Myriad Genetics, Inc.MYGNNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P36
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -42.08% |
| Q3 2025 | 189.27% |
| Q2 2025 | 16.67% |
| Q1 2025 | -3614.29% |
| Q4 2024 | 112.50% |
| Q3 2024 | 11.11% |
| Q2 2024 | 76.84% |
| Q1 2024 | 60.12% |
| Q4 2023 | -72.22% |
| Q3 2023 | -101.02% |
| Q2 2023 | 65.26% |
| Q1 2023 | -154.26% |
| Q4 2022 | -8.78% |
| Q3 2022 | 63.65% |
| Q2 2022 | -6.82% |
| Q1 2022 | -296.99% |
| Q4 2021 | 68.56% |
| Q3 2021 | -375.28% |
| Q2 2021 | -113.76% |
| Q1 2021 | 417.16% |
| Q4 2020 | 66.45% |
| Q3 2020 | -320.29% |
| Q2 2020 | 100.00% |
| Q1 2020 | 360.38% |
| Q4 2019 | -136.81% |
| Q3 2019 | -52.16% |
| Q2 2019 | 760.00% |
| Q1 2019 | -90.00% |
| Q4 2018 | 438.46% |
| Q3 2018 | -85.90% |
| Q2 2018 | 436.05% |
| Q1 2018 | -72.17% |
| Q4 2017 | 41.10% |
| Q3 2017 | -39.00% |
| Q2 2017 | -9.34% |
| Q1 2017 | 36.55% |
| Q4 2016 | 759.09% |
| Q3 2016 | -108.12% |
| Q2 2016 | 19.91% |
| Q1 2016 | -11.37% |